ArticleOncogene2012

CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute.

G Zoppoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.